In a heartfelt plea, patients living with sickle cell disease in Kenya are calling on the government to subsidize the cost of hydroxyurea, a critical medication used to manage the debilitating symptoms of this chronic condition. The appeal highlights the financial strain faced by many patients, particularly those from low-income households, who struggle to afford […]
